Jose Fernando Moura, PhD(@FernandoOnco) 's Twitter Profileg
Jose Fernando Moura, PhD

@FernandoOnco

Medical Oncology focused on Breast and Lung Cancer at https://t.co/hCfxKt8kbP and https://t.co/YeizvuTGR3 Opinions are my own. 🔁not

ID:234022461

linkhttp://www.rhp.com.br calendar_today04-01-2011 17:28:31

5,5K Tweets

1,4K Followers

1,4K Following

OncoAlert(@OncoAlert) 's Twitter Profile Photo

Just Out by OUR AMAZING OncoAlert 🚨Faculty
Emre Yekedüz , Yüksel Ürün 🇹🇷and team Sati Coskun Yazgan, Erman Akkus

Thromboembolic Risk in Patients Treated with PARP Inhibitors

Meta-analysis of phase II and phase III clinical trials examining the use of poly

Just Out by OUR AMAZING @OncoAlert 🚨Faculty @yekeduz_emre , @DrYukselUrun 🇹🇷and team Sati Coskun Yazgan, @Erman_Akkus Thromboembolic Risk in #ProstateCancer Patients Treated with PARP Inhibitors Meta-analysis of phase II and phase III clinical trials examining the use of poly
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Just out from our friends at Cancer Discovery
by Elsa Anagnostou & Victor Velculescu of Johns Hopkins University

Special commentary just out on pushing the boundaries of liquid biopsies for early precision intervention

Liquid biopsies🩸🧬represent a transformative approach in care, offering

Just out from our friends at @CD_AACR by @ValsamoA & Victor Velculescu of @JohnsHopkins Special commentary just out on pushing the boundaries of liquid biopsies for early precision intervention Liquid biopsies🩸🧬represent a transformative approach in #cancer care, offering
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Just out at npj Breast Cancer
The monarchE trial 🦋findings indicate that adjuvant abemaciclib offers:

➡️ significant improvements📈in invasive DFS and distant relapse-free survival for high-risk early patients with sustained benefit beyond the treatment period,

Just out at npj Breast Cancer The monarchE trial 🦋findings indicate that adjuvant abemaciclib offers: ➡️ significant improvements📈in invasive DFS and distant relapse-free survival for high-risk early #BreastCancer patients with sustained benefit beyond the treatment period,
account_circle
Nikolas Ferreira(@nikolas_dm) 's Twitter Profile Photo

Ajuizarei uma ação popular diante das suspeitas de irregularidades na licitação milionária promovida pelo governo Lula, visando impulsionar a popularidade do presidente. As empresas ganhoradoras do processo licitatório são próximas de ministros e deputados petistas, e o resultado

Ajuizarei uma ação popular diante das suspeitas de irregularidades na licitação milionária promovida pelo governo Lula, visando impulsionar a popularidade do presidente. As empresas ganhoradoras do processo licitatório são próximas de ministros e deputados petistas, e o resultado
account_circle
Jose Fernando Moura, PhD(@FernandoOnco) 's Twitter Profile Photo

This is not the future, this is the present!
👏🏻👏🏻 ⁦OncoAlert
Welcoming the Era of Gene Editing in Medicine | New England Journal of Medicine ⁦NEJM⁩ nejm.org/doi/full/10.10…

account_circle
Dr. Iván R. González(@Dr_Ivanoncologo) 's Twitter Profile Photo

🔬 Update on the use of radioactive☢️ iodine in thyroid cancer and teragnosis as a new approach to treatment assessment! We delve into how this technique is revolutionizing both therapeutic and diagnostic strategies. OncoReporte Jose Fernando Moura, PhD

🔬 Update on the use of radioactive☢️ iodine in thyroid cancer and teragnosis as a new approach to treatment assessment! We delve into how this technique is revolutionizing both therapeutic and diagnostic strategies. #ThyroidCancer @OncoReporte @FernandoOnco
account_circle
OncoAlert(@OncoAlert) 's Twitter Profile Photo

Siamo arrivati a Lugano🇨🇭
And what an office view ⛵️

is coming to us tomorrow and OncoAlert 🚨is beyond proud to be working with Advanced Prostate Cancer Consensus Conference in the coverage of this great conference.

Look forward to some amazing discussions and very excited to be doing that in

Siamo arrivati a Lugano🇨🇭 And what an office view ⛵️ #APCCC24 is coming to us tomorrow and @OncoAlert 🚨is beyond proud to be working with @APCCC_Lugano in the coverage of this great conference. Look forward to some amazing discussions and very excited to be doing that in
account_circle